GIM
CORZ icon

Granahan Investment Management’s Core Scientific CORZ Stock Holding History

Granahan Investment Management’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.34M Sell
208,725
-63,897
-23% -$1.5M 0.19% 111
2026
Q1 		$4.08M Sell
272,622
-78,334
-22% -$1.34M 0.2% 114
2025
Q4 		$5.11M Buy
+350,956
New +$6.12M 0.22% 103
2025
Q3 		– Sell
-411,173
Closed -$7.02M – 151
2025
Q2 		$7.02M Buy
411,173
+186,646
+83% +$1.87M 0.29% 88
2025
Q1 		$1.63M Buy
+224,527
New +$2.56M 0.08% 136

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Granahan Investment Management's CORZ Position: Q2 2026 in Review

Granahan Investment Management reduced its Core Scientific (CORZ) stake by 23% in Q2 2026, selling an estimated $1.5M and leaving 208,725 shares worth $5.34M. The position accounts for 0.19% of the portfolio, ranked #111.

Granahan Investment Management first reported a position in CORZ in Q1 2025 and has held it in 5 quarters since. The position peaked at $7.02M in Q2 2025. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Granahan Investment Management held 208,725 shares of Core Scientific worth $5.34M as of Q2 2026.
  • Granahan Investment Management sold 63,897 Core Scientific shares in Q2 2026, an estimated $1.5M.
  • Core Scientific made up 0.19% of Granahan Investment Management's portfolio in Q2 2026, its #111 holding.
  • Granahan Investment Management first reported a position in Core Scientific in Q1 2025 and has held it in 5 quarters since.
  • Granahan Investment Management's Core Scientific position peaked at $7.02M in Q2 2025.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Granahan Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.